Your Location：
Home >
Browse articles >
Regulation of Nrf2 Pathway by Traditional Chinese Medicine in Prevention and Treatment of Alzheimer's Disease： A Review
Updated：2024-04-16
Previous|Next

    • Regulation of Nrf2 Pathway by Traditional Chinese Medicine in Prevention and Treatment of Alzheimer's Disease： A Review

      Enhanced Publication
    • ZHANG Jian , LI Quan , ZHOU Yanyan
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 9, Pages: 219-227(2024)

    • DOI： 10.13422/j.cnki.syfjx.20240305     

      CLC：

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • References

  • Publication Info

  • Metrics

361

Views

400

Downloads

5

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Treatment of Alzheimer's Disease with Traditional Chinese Medicine： A Review
Si Junzitang Ameliorates Alzheimer's Disease by Regulating Keap1/Nrf2/HO-1 Signaling Pathway
Regulatory Pathways of Mitochondrial Dynamics Imbalance in Alzheime's Disease and Traditional Chinese Medicine Intervention： A Review
Advances in Diabetic Peripheral Neuropathy Treatment by Traditional Chinese Medicine Based on Cellular Senescence： A Review
Traditional Chinese Medicine Intervention in Parkinson's Disease Based on Keap1/Nrf2/ARE Signaling Pathway： A Review

Related Author

XU Zheng
TANG Yuan
QIU Fenglan
LI Yiguang
YANG Lingyu
CHEN Jie
TANG Yuan
QIU Fenglan

Related Institution

School of Pharmacy，Jiangxi University of Chinese Medicine
Jiangzhong Pharmaceutical Co. Ltd.
Jiangzhong Pharmaceutical Co. Ltd
Jiangxi Key Laboratory for Innovation and Improvement of Traditional Chinese Medicine（TCM）， Key Laboratory of Modern Chinese Medicine Preparation， Ministry of Education， Jiangxi University of Chinese Medicine
College of TCM， Jiangxi University of Chinese Medicine